Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles.
In this retrospective study of 74 oocyte-donor IVF cycles, the rates of fertilization, implantation, clinical pregnancy, ongoing pregnancy, and early pregnancy loss were similar after an agonist or hCG trigger. These findings suggest that the agonist trigger is a viable alternative for oocyte donors with significant risk factors for ovarian hyperstimulation syndrome.
Shapiro
Bruce S
BS
Fertility Center of Las Vegas, Las Vegas, Nevada 89117, USA. bsshapiro@aol.com
Daneshmand
Said T
ST
Garner
Forest C
FC
Aguirre
Martha
M
Ross
Richard
R
D000328:Adult; D006063:Chorionic Gonadotropin / Q000819:agonists* / Q000502:physiology; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists* / Q000502:physiology; D006801:Humans; D018587:Oocyte Donation; D009865:Oocytes / Q000166:cytology / Q000254:growth & development*; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology; D012189:Retrospective Studies
D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone